TSHA Insider Trading

Insider Ownership Percentage: 2.70%
Insider Buying (Last 12 Months): $15,733,000.00
Insider Selling (Last 12 Months): $351,334.11

Taysha Gene Therapies Insider Trading History Chart

This chart shows the insider buying and selling history at Taysha Gene Therapies by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Taysha Gene Therapies Share Price & Price History

Current Price: $2.95
Price Change: Price Increase of +0.06 (2.08%)
As of 05/22/2024 03:10 PM ET

This chart shows the closing price history over time for TSHA up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Taysha Gene Therapies Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/17/2023Paul B. ManningMajor ShareholderBuy100,000$1.63$163,000.0016,566,667View SEC Filing Icon  
8/24/2023Kamran AlamCFOSell33,000$2.33$76,890.00258,042View SEC Filing Icon  
8/16/2023John A Stalfort IIIDirectorBuy388,889$0.90$350,000.10999,381View SEC Filing Icon  
8/16/2023Paul B. ManningMajor ShareholderBuy16,466,667$0.90$14,820,000.3016,466,667View SEC Filing Icon  
8/16/2023Sean P. NolanCEOBuy444,444$0.90$399,999.601,535,545View SEC Filing Icon  
7/12/2023R.A. Session, IIMajor ShareholderSell80,528$0.71$57,174.888,877,091View SEC Filing Icon  
6/22/2023R.A. Session, IIMajor ShareholderSell10,508$0.70$7,355.608,975,719View SEC Filing Icon  
6/20/2023R.A. Session, IIMajor ShareholderSell295,653$0.71$209,913.639,125,189View SEC Filing Icon  
5/16/2023Sukumar NagendranInsiderBuy5,000$0.68$3,400.0034,226View SEC Filing Icon  
10/31/2022Paul B. ManningDirectorBuy1,500,000$2.00$3,000,000.001,642,202View SEC Filing Icon  
8/22/2022Kamran AlamCFOSell9,717$3.50$34,009.50269,446View SEC Filing Icon  
8/18/2022Kamran AlamCFOSell7,476$3.87$28,932.12290,645View SEC Filing Icon  
7/5/2022Suyash PrasadCMOSell3,905$3.51$13,706.55539,545View SEC Filing Icon  
7/1/2022Suyash PrasadCMOSell23,923$3.53$84,448.19543,450View SEC Filing Icon  
6/29/2022Suyash PrasadCMOSell12,324$3.81$46,954.44581,265View SEC Filing Icon  
2/2/2022Phillip B. DonenbergDirectorBuy3,000$7.78$23,340.00View SEC Filing Icon  
11/23/2021Paul B. ManningDirectorBuy20,000$12.54$250,800.00View SEC Filing Icon  
11/23/2021R.A. Session, IICEOBuy42,518$12.44$528,923.92View SEC Filing Icon  
8/20/2021Kamran AlamCFOSell11,840$16.78$198,675.20319,928View SEC Filing Icon  
8/18/2021Kamran AlamCFOSell11,193$17.35$194,198.55319,928View SEC Filing Icon  
5/20/2021Sean P. NolanDirectorBuy1,170$22.35$26,149.501,170View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Taysha Gene Therapies (NASDAQ:TSHA)

77.70% of Taysha Gene Therapies stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at TSHA by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Taysha Gene Therapies Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/17/2024RA Capital Management L.P.10,872,503$31.20M0.4%-41.1%5.814%Search for SEC Filing on Google Icon
5/17/2024Artal Group S.A.3,687,548$10.58M0.3%+0.7%1.972%Search for SEC Filing on Google Icon
5/15/2024Price T Rowe Associates Inc. MD1,099,329$3.16M0.0%-10.4%0.588%Search for SEC Filing on Google Icon
5/15/2024Avoro Capital Advisors LLC18,650,000$53.53M0.6%+328.2%9.972%Search for SEC Filing on Google Icon
5/14/2024EntryPoint Capital LLC122,905$0.35M0.3%-57.9%0.066%Search for SEC Filing on Google Icon
5/14/2024StemPoint Capital LP1,087,785$3.12M0.8%N/A0.582%Search for SEC Filing on Google Icon
5/10/2024Acadian Asset Management LLC26,477$75K0.0%-94.2%0.014%Search for SEC Filing on Google Icon
5/10/2024Vanguard Group Inc.5,917,414$16.98M0.0%-4.5%3.164%Search for SEC Filing on Google Icon
5/7/2024Quantum Private Wealth LLC698,520$2.01M0.7%+9.2%0.374%Search for SEC Filing on Google Icon
4/29/2024China Universal Asset Management Co. Ltd.35,908$0.10M0.0%+66.1%0.019%Search for SEC Filing on Google Icon
4/17/2024Cannon Global Investment Management LLC24,200$69K0.2%N/A0.013%Search for SEC Filing on Google Icon
2/23/2024Chicago Partners Investment Group LLC134,851$0.24M0.0%+21.4%0.072%Search for SEC Filing on Google Icon
2/14/2024ADAR1 Capital Management LLC209,000$0.37M0.1%N/A0.112%Search for SEC Filing on Google Icon
2/14/2024Avoro Capital Advisors LLC4,355,555$7.71M0.1%+11.0%2.330%Search for SEC Filing on Google Icon
2/9/2024Dynamic Technology Lab Private Ltd17,389$31K0.0%N/A0.009%Search for SEC Filing on Google Icon
2/7/2024Monaco Asset Management SAM295,000$0.52M0.2%N/A0.158%Search for SEC Filing on Google Icon
2/7/2024Kovitz Investment Group Partners LLC277,778$0.49M0.0%+1,011.1%0.149%Search for SEC Filing on Google Icon
2/5/2024Victory Capital Management Inc.15,600$28K0.0%N/A0.008%Search for SEC Filing on Google Icon
1/30/2024Quantum Private Wealth LLC639,520$1.13M0.5%+11.1%0.342%Search for SEC Filing on Google Icon
1/30/2024Howard Capital Management Inc.14,165$25K0.0%N/A0.008%Search for SEC Filing on Google Icon
1/26/2024Williams & Novak LLC45,000$80K0.1%N/A0.024%Search for SEC Filing on Google Icon
1/24/2024China Universal Asset Management Co. Ltd.21,622$38K0.0%N/A0.012%Search for SEC Filing on Google Icon
12/18/2023Vanguard Group Inc.5,327,864$16.84M0.0%+235.2%2.850%Search for SEC Filing on Google Icon
12/6/2023Citigroup Inc.281,119$0.89M0.0%N/A0.150%Search for SEC Filing on Google Icon
11/22/2023Polar Capital Holdings Plc2,530,000$8M0.1%N/A1.353%Search for SEC Filing on Google Icon
11/15/2023RA Capital Management L.P.18,472,503$58.37M1.1%N/A9.880%Search for SEC Filing on Google Icon
11/15/2023RTW Investments LP16,893,185$53.38M1.1%N/A9.036%Search for SEC Filing on Google Icon
11/15/2023Kynam Capital Management LP3,281,313$10.37M1.7%N/A1.755%Search for SEC Filing on Google Icon
11/15/2023Acuta Capital Partners LLC3,827,926$12.10M8.1%N/A2.047%Search for SEC Filing on Google Icon
11/15/2023Adage Capital Partners GP L.L.C.1,500,000$4.74M0.0%N/A0.802%Search for SEC Filing on Google Icon
11/14/2023Schonfeld Strategic Advisors LLC720,043$2.28M0.0%N/A0.385%Search for SEC Filing on Google Icon
11/13/2023EAM Investors LLC335,390$1.06M0.2%N/A0.179%Search for SEC Filing on Google Icon
11/13/2023FMR LLC24,527,801$77.51M0.0%+2,035.0%13.119%Search for SEC Filing on Google Icon
11/9/2023Lee Financial Co20,000$63K0.0%N/A0.011%Search for SEC Filing on Google Icon
11/9/2023Citigroup Inc.281,119$0.89M0.0%N/A0.150%Search for SEC Filing on Google Icon
11/9/2023Kovitz Investment Group Partners LLC25,000$79K0.0%+66.7%0.013%Search for SEC Filing on Google Icon
11/2/2023Quantum Private Wealth LLC575,380$1.82M0.9%+14.1%0.308%Search for SEC Filing on Google Icon
10/27/2023TD Asset Management Inc175,600$0.56M0.0%N/A0.094%Search for SEC Filing on Google Icon
10/26/2023Chicago Partners Investment Group LLC111,111$0.35M0.0%N/A0.059%Search for SEC Filing on Google Icon
10/24/2023Bank of New York Mellon Corp26,074$82K0.0%N/A0.014%Search for SEC Filing on Google Icon
10/23/2023Commonwealth Equity Services LLC26,971$85K0.0%+44.0%0.014%Search for SEC Filing on Google Icon
10/16/2023Capital Investment Advisors LLC10,000$32K0.0%N/A0.005%Search for SEC Filing on Google Icon
8/10/2023Carlson Capital L P484,000$0.32M0.0%-4.0%0.753%Search for SEC Filing on Google Icon
8/7/2023Acadian Asset Management LLC70,798$46K0.0%-82.5%0.110%Search for SEC Filing on Google Icon
8/3/2023Dynamic Advisor Solutions LLC45,000$30K0.0%N/A0.070%Search for SEC Filing on Google Icon
7/27/2023Quantum Private Wealth LLC504,380$0.33M0.2%+40.4%0.785%Search for SEC Filing on Google Icon
5/1/2023Virtu Financial LLC45,459$36K0.0%N/A0.071%Search for SEC Filing on Google Icon
4/19/2023Quantum Private Wealth LLC359,367$0.29M0.2%+14.6%0.560%Search for SEC Filing on Google Icon
2/15/2023Nantahala Capital Management LLC2,999,765$6.78M0.4%+86.2%4.804%Search for SEC Filing on Google Icon
2/13/2023GSA Capital Partners LLP183,857$0.42M0.1%-22.1%0.294%Search for SEC Filing on Google Icon
2/13/2023Artal Group S.A.1,440,882$3.26M0.2%+38.4%2.308%Search for SEC Filing on Google Icon
2/7/2023Commonwealth Equity Services LLC13,725$31K0.0%N/A0.022%Search for SEC Filing on Google Icon
2/1/2023Bank of Montreal Can202,199$0.46M0.0%N/A0.324%Search for SEC Filing on Google Icon
2/1/2023Redwood Wealth Management Group LLC35,600$80K0.1%N/A0.057%Search for SEC Filing on Google Icon
1/31/2023Sargent Investment Group LLC42,987$97K0.0%+70.3%0.069%Search for SEC Filing on Google Icon
1/20/2023Quantum Private Wealth LLC313,457$0.71M0.4%+36.8%0.502%Search for SEC Filing on Google Icon
1/19/2023Kovitz Investment Group Partners LLC15,000$34K0.0%N/A0.024%Search for SEC Filing on Google Icon
11/16/2022Alphabet Inc.640,882$1.24M0.1%N/A1.560%Search for SEC Filing on Google Icon
11/15/2022Carlson Capital L P200,000$0.39M0.0%+21.2%0.487%Search for SEC Filing on Google Icon
11/14/2022Ergoteles LLC76,743$0.15M0.0%-16.4%0.187%Search for SEC Filing on Google Icon
11/10/2022Nantahala Capital Management LLC1,610,822$3.25M0.2%-2.0%3.920%Search for SEC Filing on Google Icon
11/1/2022Quantum Private Wealth LLC229,069$0.44M0.3%+45.2%0.557%Search for SEC Filing on Google Icon
10/27/2022Sargent Investment Group LLC25,242$47K0.0%+41.9%0.061%Search for SEC Filing on Google Icon
8/17/2022Quantum Private Wealth LLC157,774$0.59M0.3%+3.8%0.384%Search for SEC Filing on Google Icon
8/15/2022Nantahala Capital Management LLC1,643,438$6.11M0.3%+23.2%4.053%Search for SEC Filing on Google Icon
8/15/2022Laurion Capital Management LP442,600$1.65M0.0%N/A1.092%Search for SEC Filing on Google Icon
8/12/2022Franklin Resources Inc.811,069$3.02M0.0%-37.6%2.000%Search for SEC Filing on Google Icon
8/11/2022Trexquant Investment LP19,548$73K0.0%-72.7%0.048%Search for SEC Filing on Google Icon
7/26/2022Sargent Investment Group LLC17,788$66K0.0%+66.9%0.044%Search for SEC Filing on Google Icon
7/22/2022Thompson Siegel & Walmsley LLC56,100$0.21M0.0%+33.3%0.138%Search for SEC Filing on Google Icon
5/27/2022Quantum Private Wealth LLC151,974$0.99M0.4%+4.3%0.375%Search for SEC Filing on Google Icon
5/11/2022GSA Capital Partners LLP117,109$0.76M0.1%+186.4%0.289%Search for SEC Filing on Google Icon
5/6/2022Sargent Investment Group LLC10,656$69K0.0%N/A0.026%Search for SEC Filing on Google Icon
5/6/2022TimesSquare Capital Management LLC665,900$4.34M0.0%+1.0%1.645%Search for SEC Filing on Google Icon
4/29/2022Nisa Investment Advisors LLC19,800$0.13M0.0%N/A0.051%Search for SEC Filing on Google Icon
4/26/2022Thompson Siegel & Walmsley LLC42,100$0.27M0.0%N/A0.109%Search for SEC Filing on Google Icon
2/15/2022683 Capital Management LLC10,000$0.12M0.0%N/A0.026%Search for SEC Filing on Google Icon
2/14/2022Virtus ETF Advisers LLC11,519$0.13M0.1%+39.3%0.030%Search for SEC Filing on Google Icon
2/14/2022GSA Capital Partners LLP40,885$0.48M0.1%N/A0.106%Search for SEC Filing on Google Icon
2/8/2022ProShare Advisors LLC10,368$0.12M0.0%N/A0.027%Search for SEC Filing on Google Icon
2/8/2022Northern Trust Corp214,970$2.50M0.0%+1.4%0.559%Search for SEC Filing on Google Icon
2/7/2022Mitsubishi UFJ Kokusai Asset Management Co. Ltd.21,834$0.26M0.0%N/A0.057%Search for SEC Filing on Google Icon
2/4/2022TimesSquare Capital Management LLC659,100$7.68M0.1%+1.3%1.713%Search for SEC Filing on Google Icon
11/15/2021California State Teachers Retirement System25,954$0.48M0.0%-15.5%0.068%Search for SEC Filing on Google Icon
11/15/2021Franklin Resources Inc.1,310,210$24.40M0.0%+0.3%3.413%Search for SEC Filing on Google Icon
11/12/2021Macquarie Group Ltd.2,210$41K0.0%N/A0.006%Search for SEC Filing on Google Icon
11/12/2021Geode Capital Management LLC363,016$6.76M0.0%+37.8%0.946%Search for SEC Filing on Google Icon
11/10/2021Granite Point Capital Management L.P.40,000$0.75M0.1%-20.0%0.104%Search for SEC Filing on Google Icon
11/10/2021Citigroup Inc.3,321$62K0.0%+142.2%0.009%Search for SEC Filing on Google Icon
11/9/2021BlackRock Inc.3,021,969$56.27M0.0%+1.9%7.872%Search for SEC Filing on Google Icon
11/9/2021University of Texas Texas AM Investment Managment Co.1,147,040$21.36M12.2%-17.5%2.988%Search for SEC Filing on Google Icon
11/8/2021TimesSquare Capital Management LLC650,600$12.11M0.1%-4.8%1.695%Search for SEC Filing on Google Icon
11/4/2021Sands Capital Ventures LLC724,873$13.50M2.0%N/A1.888%Search for SEC Filing on Google Icon
11/2/2021New York State Common Retirement Fund14,327$0.27M0.0%-25.3%0.037%Search for SEC Filing on Google Icon
11/1/2021SG Americas Securities LLC9,168$0.17M0.0%N/A0.024%Search for SEC Filing on Google Icon
8/17/2021Perceptive Advisors LLC320,440$6.79M0.1%-31.9%0.845%Search for SEC Filing on Google Icon
8/17/2021Metropolitan Life Insurance Co NY7,280$0.15M0.0%N/A0.019%Search for SEC Filing on Google Icon
8/17/2021MetLife Investment Management LLC9,509$0.20M0.0%N/A0.025%Search for SEC Filing on Google Icon
8/16/2021Nantahala Capital Management LLC432,072$9.16M0.3%+1,069.2%1.140%Search for SEC Filing on Google Icon
8/16/2021California State Teachers Retirement System30,712$0.65M0.0%+133.9%0.081%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Taysha Gene Therapies logo
Taysha Gene Therapies, Inc., a gene therapy company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. It primarily develops TSHA-120 for the treatment of giant axonal neuropathy; TSHA-102 for the treatment of Rett syndrome; TSHA-121 for the treatment of CLN7 disease; TSHA-118 for the treatment of CLN1 disease; TSHA-105 for the treatment of for SLC13A5 deficiency; TSHA-113 for the treatment of tauopathies; TSHA-106 for the treatment of angelman syndrome; TSHA-114 for the treatment of fragile X syndrome; and TSHA-101 for the treatment of GM2 gangliosidosis. Taysha Gene Therapies, Inc. has a strategic partnership with The University of Texas Southwestern Medical Center. Taysha Gene Therapies, Inc. was incorporated in 2019 and is headquartered in Dallas, Texas.
Read More on Taysha Gene Therapies

Today's Range

Now: $2.95
Low: $2.84
High: $3.04

50 Day Range

MA: $2.67
Low: $2.13
High: $3.25

52 Week Range

Now: $2.95
Low: $0.50
High: $3.89

Volume

1,334,000 shs

Average Volume

2,399,242 shs

Market Capitalization

$551.71 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.37

Who are the company insiders with the largest holdings of Taysha Gene Therapies?

Taysha Gene Therapies' top insider investors include:
  1. Paul B Manning (Major Shareholder)
  2. RA Session II (Major Shareholder)
  3. Paul B Manning (Director)
  4. Sean P Nolan (CEO)
  5. John A Stalfort III (Director)
  6. Suyash Prasad (CMO)
  7. Kamran Alam (CFO)
  8. Sukumar Nagendran (Insider)
Learn More about top insider investors at Taysha Gene Therapies.

Who are the major institutional investors of Taysha Gene Therapies?

Taysha Gene Therapies' top institutional investors include:
  1. Avoro Capital Advisors LLC — 9.97%
  2. RA Capital Management L.P. — 5.81%
  3. Vanguard Group Inc. — 3.16%
  4. Artal Group S.A. — 1.97%
  5. Price T Rowe Associates Inc. MD — 0.59%
  6. StemPoint Capital LP — 0.58%
Learn More about top institutional investors of Taysha Gene Therapies stock.

Which institutional investors are selling Taysha Gene Therapies stock?

In the last quarter, TSHA stock was sold by these institutional investors:
  1. RA Capital Management L.P.
  2. Acadian Asset Management LLC
  3. Vanguard Group Inc.
  4. EntryPoint Capital LLC
  5. Price T Rowe Associates Inc. MD
Within the last year, company insiders that have sold Taysha Gene Therapies company stock include:
  1. Paul B Manning (Major Shareholder)
  2. RA Session II (Major Shareholder)
Learn More investors selling Taysha Gene Therapies stock.

Which institutional investors are buying Taysha Gene Therapies stock?

During the previous quarter, TSHA stock was purchased by institutional investors including:
  1. Avoro Capital Advisors LLC
  2. StemPoint Capital LP
  3. Quantum Private Wealth LLC
  4. Artal Group S.A.
  5. Cannon Global Investment Management LLC
  6. China Universal Asset Management Co. Ltd.
In the last year, these company insiders have bought Taysha Gene Therapies stock:
  1. Paul B Manning (Major Shareholder)
  2. RA Session II (Major Shareholder)
  3. Paul B Manning (Director)
  4. Sean P Nolan (CEO)
  5. John A Stalfort III (Director)
Learn More investors buying Taysha Gene Therapies stock.